Poland - Rybnik: Antineoplastic and immunomodulating agents

Release

ID: ocds-pyfy63:2022-562344:2023-116165
Buyer: Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Specjalistyczny Nr 3 w Rybniku
Date: 2023-02-24
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2022-562344
Releases: 2022-10-14 (ocds-pyfy63:2022-562344:2022-562344)
2023-02-24 (ocds-pyfy63:2022-562344:2023-116165)

Releases in JSON

Tender

Title: Poland - Rybnik: Antineoplastic and immunomodulating agents
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award criteria for item 66:
- Price

Award criteria for item 67:
- Price

Award criteria for item 68:
- Price

Award criteria for item 69:
- Price

Award criteria for item 70:
- Price

Award criteria for item 71:
- Price

Award criteria for item 72:
- Price

Award criteria for item 73:
- Price

Award criteria for item 74:
- Price

Award criteria for item 75:
- Price

Award criteria for item 76:
- Price

Award criteria for item 77:
- Price

Award criteria for item 78:
- Price

Award criteria for item 79:
- Price

Award criteria for item 80:
- Price

Award criteria for item 81:
- Price

Award criteria for item 82:
- Price

Award criteria for item 83:
- Price

Award criteria for item 84:
- Price

Award criteria for item 85:
- Price

Award criteria for item 86:
- Price

Award criteria for item 87:
- Price

Award criteria for item 88:
- Price

Award criteria for item 89:
- Price

Award criteria for item 90:
- Price

Award criteria for item 91:
- Price

Award criteria for item 92:
- Price

Award criteria for item 93:
- Price

Award criteria for item 94:
- Price

Award criteria for item 95:
- Price

Award criteria for item 96:
- Price

Award criteria for item 97:
- Price

Award criteria for item 98:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2023-02-24 - ?
Tenderers: Farmacol Logistyka Sp. z o. o.
Asclepios S.A.
Centrala Farmaceutyczna CEFARM S.A.
Urtica Sp. z o.o.
Salus International Sp. z o. o.
Bialmed Sp. z o. o.
Astrazeneca Kft.
Janssen - Cilag Polska Sp. z o. o.
Komtur Polska Sp. z o. o.
Servier Polska Services Sp. z o.o.
Fresenius Kabi Polska Sp. z o. o.
Delfarma Sp. z o.o.
URTICA Sp. z o. o.
URTICA Sp.zo.o.
Sanofi-Aventis Sp. z o. o.
URTICA Sp.z o. o.
„Roche Polska” Sp. z o. o.
Urtica Sp. z o. o.
Takeda Pharma Sp. z o. o.
BAXTER Polska Sp. z o. o.
Optifarma Sp. z o. o. Spółka komandytowa
Sanofi-Aventis Sp. z o. o.
Amgen Sp. z o. o.
Amgen Sp.z o. o.
Asclepios S.A
Egis Polska Dystrybucja Sp. z o. o.
AbbvieSp. z o. o.
Amgen Sp. z o. o.
GSK Services Sp. z o. o.

Tender item

ID: ocds-pyfy63:2022-562344:obj:1
Classification: CPV / 33652000
Description: Abirateroni acetas

Tender item

ID: ocds-pyfy63:2022-562344:obj:2
Classification: CPV / 33652000
Description: Anagrelid

Tender item

ID: ocds-pyfy63:2022-562344:obj:3
Classification: CPV / 33652000
Description: Aprepitantum

Tender item

ID: ocds-pyfy63:2022-562344:obj:4
Classification: CPV / 33652000
Description: Axitinibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:5
Classification: CPV / 33652000
Description: Bicalutamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:6
Classification: CPV / 33652000
Description: Bicalutamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:7
Classification: CPV / 33652000
Description: Capecitabinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:8
Classification: CPV / 33652000
Description: Enzalutamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:9
Classification: CPV / 33652000
Description: Erlotinibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:10
Classification: CPV / 33652000
Description: Everolimusum

Tender item

ID: ocds-pyfy63:2022-562344:obj:11
Classification: CPV / 33652000
Description: Hydroxycarbamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:12
Classification: CPV / 33652000
Description: Melphalanum

Tender item

ID: ocds-pyfy63:2022-562344:obj:13
Classification: CPV / 33652000
Description: Netupitant, Palonosetron

Tender item

ID: ocds-pyfy63:2022-562344:obj:14
Classification: CPV / 33652000
Description: Pazopanibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:15
Classification: CPV / 33652000
Description: Sunitinibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:16
Classification: CPV / 33652000
Description: Temozolomidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:17
Classification: CPV / 33652000
Description: Vinorelbinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:18
Classification: CPV / 33652000
Description: Topotecanum

Tender item

ID: ocds-pyfy63:2022-562344:obj:19
Classification: CPV / 33652000
Description: Sorafenibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:20
Classification: CPV / 33652000
Description: Olaparib

Tender item

ID: ocds-pyfy63:2022-562344:obj:21
Classification: CPV / 33652000
Description: Crizotinib

Tender item

ID: ocds-pyfy63:2022-562344:obj:22
Classification: CPV / 33652000
Description: Cabozantynib

Tender item

ID: ocds-pyfy63:2022-562344:obj:23
Classification: CPV / 33652000
Description: Lapatynib

Tender item

ID: ocds-pyfy63:2022-562344:obj:24
Classification: CPV / 33652000
Description: Ibrutinib

Tender item

ID: ocds-pyfy63:2022-562344:obj:25
Classification: CPV / 33652000
Description: Osimertinibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:26
Classification: CPV / 33652000
Description: Lenalidomid

Tender item

ID: ocds-pyfy63:2022-562344:obj:27
Classification: CPV / 33652000
Description: Pomalidomide

Tender item

ID: ocds-pyfy63:2022-562344:obj:28
Classification: CPV / 33652000
Description: Palbociclibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:29
Classification: CPV / 33652000
Description: Ribociclibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:30
Classification: CPV / 33652000
Description: Abemaciclibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:31
Classification: CPV / 33652000
Description: Eltrombopagum

Tender item

ID: ocds-pyfy63:2022-562344:obj:32
Classification: CPV / 33652000
Description: Trifluridinum+Tipiracilum

Tender item

ID: ocds-pyfy63:2022-562344:obj:33
Classification: CPV / 33652000
Description: Ondansetronum

Tender item

ID: ocds-pyfy63:2022-562344:obj:34
Classification: CPV / 33652000
Description: Mesnum

Tender item

ID: ocds-pyfy63:2022-562344:obj:35
Classification: CPV / 33652000
Description: Filgrastimum

Tender item

ID: ocds-pyfy63:2022-562344:obj:36
Classification: CPV / 33652000
Description: Natalizumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:37
Classification: CPV / 33652000
Description: Glatiramer acetate

Tender item

ID: ocds-pyfy63:2022-562344:obj:38
Classification: CPV / 33652000
Description: Interferon beta - 1 a

Tender item

ID: ocds-pyfy63:2022-562344:obj:39
Classification: CPV / 33652000
Description: Interferon beta - 1 b

Tender item

ID: ocds-pyfy63:2022-562344:obj:40
Classification: CPV / 33652000
Additional classifications: CPV / 33693100
Description: Toxinum botulinicum

Tender item

ID: ocds-pyfy63:2022-562344:obj:41
Classification: CPV / 33652000
Additional classifications: CPV / 33693100
Description: Toxinum botulinicum

Tender item

ID: ocds-pyfy63:2022-562344:obj:42
Classification: CPV / 33652000
Description: Dimethylis fumaras

Tender item

ID: ocds-pyfy63:2022-562344:obj:43
Classification: CPV / 33652000
Description: Fingolimod

Tender item

ID: ocds-pyfy63:2022-562344:obj:44
Classification: CPV / 33652000
Description: Teriflunomid, Alemtuzumab

Tender item

ID: ocds-pyfy63:2022-562344:obj:45
Classification: CPV / 33652000
Description: Interferon beta -1 a

Tender item

ID: ocds-pyfy63:2022-562344:obj:46
Classification: CPV / 33652000
Description: Ocrelizumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:47
Classification: CPV / 33652000
Description: Cladribinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:48
Classification: CPV / 33652000
Description: Bendamustinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:49
Classification: CPV / 33652000
Description: Bleomycini sulfas

Tender item

ID: ocds-pyfy63:2022-562344:obj:50
Classification: CPV / 33652000
Description: Bortezomid

Tender item

ID: ocds-pyfy63:2022-562344:obj:51
Classification: CPV / 33652000
Description: Brentuksymabu vedotin

Tender item

ID: ocds-pyfy63:2022-562344:obj:52
Classification: CPV / 33652000
Description: Cyclophosphamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:53
Classification: CPV / 33652000
Description: Dacarbazinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:54
Classification: CPV / 33652000
Description: Doxorubicinum liposomanum nonpegylatum

Tender item

ID: ocds-pyfy63:2022-562344:obj:55
Classification: CPV / 33652000
Description: Doxorubicinum liposomanum pegylatum

Tender item

ID: ocds-pyfy63:2022-562344:obj:56
Classification: CPV / 33652000
Description: Ifosfamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:57
Classification: CPV / 33652000
Description: Paclitaxel

Tender item

ID: ocds-pyfy63:2022-562344:obj:58
Classification: CPV / 33652000
Description: Topotecanum

Tender item

ID: ocds-pyfy63:2022-562344:obj:59
Classification: CPV / 33652000
Description: Trabectedinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:60
Classification: CPV / 33652000
Description: Vincristini sulfas

Tender item

ID: ocds-pyfy63:2022-562344:obj:61
Classification: CPV / 33652000
Description: Aflibercept

Tender item

ID: ocds-pyfy63:2022-562344:obj:62
Classification: CPV / 33652000
Description: Atezolizumab

Tender item

ID: ocds-pyfy63:2022-562344:obj:63
Classification: CPV / 33652000
Description: Bevacizumab

Tender item

ID: ocds-pyfy63:2022-562344:obj:64
Classification: CPV / 33652000
Description: Obinutuzumab

Tender item

ID: ocds-pyfy63:2022-562344:obj:65
Classification: CPV / 33652000
Description: Trastuzumabum emtansinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:66
Classification: CPV / 33652000
Description: Trastuzumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:67
Classification: CPV / 33652000
Description: Panitumumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:68
Classification: CPV / 33652000
Description: Pertuzumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:69
Classification: CPV / 33652000
Description: Cetuximabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:70
Classification: CPV / 33652000
Description: Pembrolizumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:71
Classification: CPV / 33652000
Description: Daratumumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:72
Classification: CPV / 33652000
Description: Temsyrolimus

Tender item

ID: ocds-pyfy63:2022-562344:obj:73
Classification: CPV / 33652000
Description: Cladribinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:74
Classification: CPV / 33652000
Description: Nivolumab

Tender item

ID: ocds-pyfy63:2022-562344:obj:75
Classification: CPV / 33652000
Description: Romiplostim

Tender item

ID: ocds-pyfy63:2022-562344:obj:76
Classification: CPV / 33652000
Description: Piksantron

Tender item

ID: ocds-pyfy63:2022-562344:obj:77
Classification: CPV / 33652000
Description: Rituximabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:78
Classification: CPV / 33652000
Description: Acidum levofolinicum, Fluorouracil

Tender item

ID: ocds-pyfy63:2022-562344:obj:79
Classification: CPV / 33652000
Description: Cytostatyki różne

Tender item

ID: ocds-pyfy63:2022-562344:obj:80
Classification: CPV / 33652000
Description: Irinotecan

Tender item

ID: ocds-pyfy63:2022-562344:obj:81
Classification: CPV / 33652000
Description: Oxaliplatinum

Tender item

ID: ocds-pyfy63:2022-562344:obj:82
Classification: CPV / 33652000
Description: Paclitaxelum

Tender item

ID: ocds-pyfy63:2022-562344:obj:83
Classification: CPV / 33652000
Description: Pemetreksedum

Tender item

ID: ocds-pyfy63:2022-562344:obj:84
Classification: CPV / 33652000
Description: Trastuzumabum

Tender item

ID: ocds-pyfy63:2022-562344:obj:85
Classification: CPV / 33652000
Description: Afatinib

Tender item

ID: ocds-pyfy63:2022-562344:obj:86
Classification: CPV / 33652000
Description: Preparat do sporządzania zawiesiny do podawania do pęcherza moczowego

Tender item

ID: ocds-pyfy63:2022-562344:obj:87
Classification: CPV / 33652000
Description: Ondansetron

Tender item

ID: ocds-pyfy63:2022-562344:obj:88
Classification: CPV / 33652000
Description: Venetoclaxum

Tender item

ID: ocds-pyfy63:2022-562344:obj:89
Classification: CPV / 33652000
Description: Karfilzomib

Tender item

ID: ocds-pyfy63:2022-562344:obj:90
Classification: CPV / 33652000
Description: Pegfilgrastim

Tender item

ID: ocds-pyfy63:2022-562344:obj:91
Classification: CPV / 33652000
Description: Apalutamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:92
Classification: CPV / 33652000
Description: Darolutamidum

Tender item

ID: ocds-pyfy63:2022-562344:obj:93
Classification: CPV / 33652000
Description: Niraparibum

Tender item

ID: ocds-pyfy63:2022-562344:obj:94
Classification: CPV / 33652000
Description: Nintedanib

Tender item

ID: ocds-pyfy63:2022-562344:obj:95
Classification: CPV / 33652000
Additional classifications: CPV / 33621300
Description: Darbepoetyna alfa

Tender item

ID: ocds-pyfy63:2022-562344:obj:96
Classification: CPV / 33652000
Description: Fludarabine

Tender item

ID: ocds-pyfy63:2022-562344:obj:97
Classification: CPV / 33652000
Description: Vinblastin

Tender item

ID: ocds-pyfy63:2022-562344:obj:98
Classification: CPV / 33652000
Description: Mitomycinum

Award

ID: ocds-pyfy63:2022-562344:award:0
Title: Abirateroni acetas
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:1
Title: Anagrelid
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:2
Title: Aprepitantum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:3
Title: Axitinibum
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:4
Title: Bicalutamidum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:5
Title: Bicalutamidum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:6
Title: Capecitabinum
Date: 2023-01-03
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:7
Title: Enzalutamidum
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:8
Title: Erlotinibum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:9
Title: Everolimusum
Date: 2023-01-03
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:10
Title: Hydroxycarbamidum
Date: 2023-01-03
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:11
Title: Melphalanum
Date: 2023-01-03
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:12
Title: Netupitant, Palonosetron
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:13
Title: Pazopanibum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:14
Title: Sunitinibum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:15
Title: Temozolomidum
Date: 2023-01-03
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:16
Title: Vinorelbinum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:17
Title: Topotecanum
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:18
Title: Sorafenibum
Date: 2023-01-03
Status: active
Suppliers: Bialmed Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:19
Title: Olaparib
Date: 2022-12-22
Status: active
Suppliers: Astrazeneca Kft.

Award

ID: ocds-pyfy63:2022-562344:award:20
Title: Crizotinib
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:21
Title: Cabozantynib
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:22
Title: Lapatynib
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:23
Title: Ibrutinib
Date: 2022-12-22
Status: active
Suppliers: Janssen - Cilag Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:24
Title: Osimertinibum
Date: 2022-12-22
Status: active
Suppliers: Astrazeneca Kft.

Award

ID: ocds-pyfy63:2022-562344:award:25
Title: Lenalidomid
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:26
Title: Pomalidomide
Date: 2022-12-22
Status: active
Suppliers: Komtur Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:27
Title: Palbociclibum
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:28
Title: Ribociclibum
Date: 2022-12-22
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:29
Title: Abemaciclibum
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:30
Title: Eltrombopagum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:31
Title: Trifluridinum+Tipiracilum
Date: 2023-01-03
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:32
Title: Ondansetronum
Date: 2023-01-03
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:33
Title: Mesnum
Date: 2023-01-03
Status: active
Suppliers: Delfarma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:34
Title: Filgrastimum
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:35
Title: Natalizumabum
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:36
Title: Glatiramer acetate
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:37
Title: Interferon beta - 1 a
Date: 2023-01-03
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:38
Title: Interferon beta - 1 b
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:39
Title: Toxinum botulinicum
Date: 2022-12-22
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:40
Title: Toxinum botulinicum
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:41
Title: Dimethylis fumaras
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp.zo.o.

Award

ID: ocds-pyfy63:2022-562344:award:42
Title: Fingolimod
Date: 2023-01-03
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:43
Title: Teriflunomid, Alemtuzumab
Date: 2023-01-03
Status: active
Suppliers: Sanofi-Aventis Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:44
Title: Interferon beta -1 a
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp.z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:45
Title: Ocrelizumabum
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:46
Title: Cladribinum
Date: 2023-01-03
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:47
Title: Bendamustinum
Date: 2023-01-03
Status: active
Suppliers: Urtica Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:48
Title: Bleomycini sulfas
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:49
Title: Bortezomid
Date: 2023-01-03
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:50
Title: Brentuksymabu vedotin
Date: 2023-01-03
Status: active
Suppliers: Takeda Pharma Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:51
Title: Cyclophosphamidum
Date: 2022-12-22
Status: active
Suppliers: BAXTER Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:52
Title: Dacarbazinum
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:53
Title: Doxorubicinum liposomanum nonpegylatum
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-562344:award:54
Title: Doxorubicinum liposomanum pegylatum
Date: 2022-12-22
Status: active
Suppliers: BAXTER Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:55
Title: Ifosfamidum
Date: 2022-12-22
Status: active
Suppliers: BAXTER Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:56
Title: Paclitaxel
Date: 2022-12-22
Status: active
Suppliers: Komtur Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:57
Title: Topotecanum
Date: 2022-12-22
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:58
Title: Trabectedinum
Date: 2023-01-03
Status: active
Suppliers: Optifarma Sp. z o. o. Spółka komandytowa

Award

ID: ocds-pyfy63:2022-562344:award:59
Title: Vincristini sulfas
Date: 2023-01-03
Status: active
Suppliers: Salus International Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:60
Title: Aflibercept
Date: 2023-01-03
Status: active
Suppliers: Sanofi-Aventis Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:61
Title: Atezolizumab
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:62
Title: Bevacizumab
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:63
Title: Obinutuzumab
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:64
Title: Trastuzumabum emtansinum
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:65
Title: Trastuzumabum
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:66
Title: Panitumumabum
Date: 2022-12-22
Status: active
Suppliers: Amgen Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:67
Title: Pertuzumabum
Date: 2022-12-22
Status: active
Suppliers: „Roche Polska” Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:68
Title: Cetuximabum
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:69
Title: Pembrolizumabum
Date: 2022-12-22
Status: active
Suppliers: Centrala Farmaceutyczna CEFARM S.A.

Award

ID: ocds-pyfy63:2022-562344:award:70
Title: Daratumumabum
Date: 2022-12-22
Status: active
Suppliers: Janssen - Cilag Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:71
Title: Temsyrolimus
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:72
Title: Cladribinum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:73
Title: Nivolumab
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp.z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:74
Title: Romiplostim
Date: 2022-12-22
Status: active
Suppliers: Amgen Sp.z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:75
Title: Piksantron
Date: 2023-01-03
Status: active
Suppliers: Servier Polska Services Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:76
Title: Rituximabum
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:77
Title: Acidum levofolinicum, Fluorouracil
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:78
Title: Cytostatyki różne
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:79
Title: Irinotecan
Date: 2023-01-03
Status: active
Suppliers: Urtica Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:80
Title: Oxaliplatinum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:81
Title: Paclitaxelum
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:82
Title: Pemetreksedum
Date: 2023-01-03
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:83
Title: Trastuzumabum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:84
Title: Afatinib
Date: 2022-12-22
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-562344:award:85
Title: Preparat do sporządzania zawiesiny do podawania do pęcherza moczowego
Date: 2022-12-22
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:86
Title: Ondansetron
Date: 2023-01-03
Status: active
Suppliers: Egis Polska Dystrybucja Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:87
Title: Venetoclaxum
Date: 2023-01-03
Status: active
Suppliers: AbbvieSp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:88
Title: Karfilzomib
Date: 2022-12-22
Status: active
Suppliers: Amgen Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:89
Title: Pegfilgrastim
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:90
Title: Apalutamidum
Date: 2022-12-22
Status: active
Suppliers: Janssen - Cilag Polska Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:91
Title: Darolutamidum
Date: 2023-01-03
Status: active
Suppliers: Farmacol Logistyka Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:92
Title: Niraparibum
Date: 2023-01-03
Status: active
Suppliers: GSK Services Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:93
Title: Nintedanib
Date: 2022-12-22
Status: active
Suppliers: URTICA Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:94
Title: Darbepoetyna alfa
Date: 2022-12-22
Status: active
Suppliers: Amgen Sp. z o. o.

Award

ID: ocds-pyfy63:2022-562344:award:95
Title: Fludarabine
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-562344:award:96
Title: Vinblastin
Date: 2023-01-03
Status: active
Suppliers: Asclepios S.A

Award

ID: ocds-pyfy63:2022-562344:award:97
Title: Mitomycinum
Date: 2023-01-03
Status: active
Suppliers: Bialmed Sp. z o. o.

Parties

Roles: buyer
Organization name: Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Specjalistyczny Nr 3 w Rybniku
Street address: ul. Energetyków 46
Locality: Rybnik
Postal code: 44-200
Country: PL
Contact name: Agnieszka Niezgodzińska (w zakresie formalnym), tel.: +48 324291287, Magdalena Wieczorek (w zakresie merytorycznym), tel.: +48 324291080, od poniedziałku do piątku w godz. 10:00–14:00
E-mail: zp@szpital.rybnik.pl
Phone: +48 324291226/87/88
Fax: +48 324291225
Website: Link